- Home
- TXMD vs CNC Comparison
TXMD vs CNC Comparison
Compare TXMD & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXMD | CNC |
|---|---|---|
| Founded | 2008 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 33.1B |
| IPO Year | 2012 | 2001 |
Fundamental Metrics
Financial Performance| Metric | TXMD | CNC |
|---|---|---|
| Price | $2.04 | $61.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $46.75 |
| AVG Volume (30 Days) | 17.5K | ★ 3.0M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.68 | N/A |
| EPS | 0.02 | ★ 5.30 |
| Revenue | $1,761,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | N/A | $8.31 |
| Revenue Next Year | N/A | $1.05 |
| P/E Ratio | $105.00 | ★ $11.63 |
| Revenue Growth | ★ 35.25 | 19.44 |
| 52 Week Low | $0.99 | $31.63 |
| 52 Week High | $2.95 | $69.63 |
Technical Indicators
Market Signals| Indicator | TXMD | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 46.26 | 39.73 |
| Support Level | $2.07 | $60.86 |
| Resistance Level | $2.16 | $68.67 |
| Average True Range (ATR) | 0.06 | 2.09 |
| MACD | -0.01 | -0.54 |
| Stochastic Oscillator | 39.06 | 4.42 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.